Clinical Trials
271
Active:13
Completed:26
Trial Phases
6 Phases
Early Phase 1:9
Phase 1:48
Phase 2:108
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (245 trials with phase data)• Click on a phase to view related trials
Phase 2
108 (44.1%)Not Applicable
62 (25.3%)Phase 1
48 (19.6%)Phase 4
13 (5.3%)Early Phase 1
9 (3.7%)Phase 3
5 (2.0%)Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients
Not Applicable
Not yet recruiting
- Conditions
- AML, Adult
- Interventions
- First Posted Date
- 2025-08-20
- Last Posted Date
- 2025-08-20
- Target Recruit Count
- 240
- Registration Number
- NCT07132684
MRD-positive AML Clinical Study
Not Applicable
Recruiting
- Conditions
- AML, Adult
- Interventions
- First Posted Date
- 2025-08-20
- Last Posted Date
- 2025-08-20
- Target Recruit Count
- 120
- Registration Number
- NCT07131059
- Locations
- 🇨🇳
Blood Diseases Hospital, Tianjin, Tianjin, China
Autologous Hematopoietic Stem Cell Infusion for Prolonged Cytopenia After CAR-T Cell Therapy
Not Applicable
Recruiting
- Conditions
- Prolonged Cytopenia Following CAR-T Therapy
- Interventions
- Biological: Autologous hematopoietic stem cell infusion
- First Posted Date
- 2025-08-17
- Last Posted Date
- 2025-08-17
- Target Recruit Count
- 20
- Registration Number
- NCT07127289
- Locations
- 🇨🇳
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin, Tianjin, China
Effect of a Simplified Mindfulness Intervention on Health-related Quality of Life in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Prospective Single-Center Randomized Controlled Trial
Not Applicable
Not yet recruiting
- Conditions
- Hematopoietic Stem Cell Transplantation
- First Posted Date
- 2025-08-17
- Last Posted Date
- 2025-08-17
- Target Recruit Count
- 148
- Registration Number
- NCT07127562
The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT
Not Applicable
Recruiting
- Conditions
- AML (Acute Myelogenous Leukemia)AML
- Interventions
- First Posted Date
- 2025-08-17
- Last Posted Date
- 2025-08-17
- Target Recruit Count
- 10
- Registration Number
- NCT07126782
- Locations
- 🇨🇳
Institute of Hematology & Blood Diseases Hospital, Beijing, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 55
- Next
News
No news found